Tor Ny
Amministratore Delegato presso Umeå Biotech Incubator AB
Profilo
Tor Ny is the founder of Omnio Healer AB, which was founded in 2006.
He held the title of Director & Chief Scientific Officer from 2010 to 2012.
Currently, Dr. Ny is the Chief Executive Officer at Umeå Biotech Incubator AB and a Professor at Umea Universitet.
Posizioni attive di Tor Ny
Società | Posizione | Inizio |
---|---|---|
Umea Universitet | Corporate Officer/Principal | 01/09/2009 |
Umeå Biotech Incubator AB
Umeå Biotech Incubator AB Investment ManagersFinance Umeå Biotech Incubator AB is a biotechnical research and development company based in Umeå, Sweden. Part of Umea Universitet, Umeå Biotech Incubator AB engages in biotechnical research and development business. The CEO of the Swedish company is Tor Ny. | Amministratore Delegato | 01/09/2009 |
Precedenti posizioni note di Tor Ny
Società | Posizione | Fine |
---|---|---|
Omnio Healer AB
Omnio Healer AB Pharmaceuticals: MajorHealth Technology Omnio Healer AB is a company developing novel drug candidates based on a series of conceptual breakthroughs in inflammation research. This new, pro-inflammatory approach opens up completely new therapeutic strategies for wound healing and anti-infection. The company's lead drug candidate, aimed primarily at otological indications, has achieved promising preclinical results and will enter a clinical development program in late 2010. Since its foundation in 2006 Omnio Healer has assembled a management and development team. This includes scientists within the field, experienced product development professionals and active investors led by Karolinska Development AB, providing access to a network of biotechnology development resources. The company is based in Umeå, Sweden. | Fondatore | 19/01/2012 |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Omnio Healer AB
Omnio Healer AB Pharmaceuticals: MajorHealth Technology Omnio Healer AB is a company developing novel drug candidates based on a series of conceptual breakthroughs in inflammation research. This new, pro-inflammatory approach opens up completely new therapeutic strategies for wound healing and anti-infection. The company's lead drug candidate, aimed primarily at otological indications, has achieved promising preclinical results and will enter a clinical development program in late 2010. Since its foundation in 2006 Omnio Healer has assembled a management and development team. This includes scientists within the field, experienced product development professionals and active investors led by Karolinska Development AB, providing access to a network of biotechnology development resources. The company is based in Umeå, Sweden. | Health Technology |
Umeå Biotech Incubator AB
Umeå Biotech Incubator AB Investment ManagersFinance Umeå Biotech Incubator AB is a biotechnical research and development company based in Umeå, Sweden. Part of Umea Universitet, Umeå Biotech Incubator AB engages in biotechnical research and development business. The CEO of the Swedish company is Tor Ny. | Finance |
- Borsa valori
- Insiders
- Tor Ny